Top news
FDA inspection found problems at factory making J&J vaccine
By Linda A. Johnson
Vaccinations are plateauing. Don't blame it on 'resistance'
By Stefanie Friedhoff
Federal Inspectors Fear More Vaccines Were Exposed to Contamination (Published 2021)
By Sharon LaFraniere, Chris Hamby & Sheryl Gay Stolberg
All coverage
Congressional investigation launched into Emergent BioSolutions' federal vaccine contracts
By Rich Mendez
COVID-19 vaccine blood clots: Should you be concerned?
By Sean Jackson
White House writes off Johnson & Johnson vaccine after string of production failures
By Sarah Owermohle, Adam Cancryn & Erin Banco
L.A. County prepping to resume administering Johnson & Johnson vaccine
By Luke Money & Colleen Shalby
U.S. ends J&J COVID-19 vaccine pause; shots to resume immediately
By Julie Steenhuysen & Manas Mishra
Johnson & Johnson Vaccine: U.S. Lifts Pause : Coronavirus Updates
By Laurel Wamsley
Johnson & Johnson COVID vaccine: Pause lifted by FDA, use to resume
By Karen Weintraub & Elizabeth Weise
CDC panel voted to resume J&J COVID-19 shots paused for clot concerns
By Tina Hesman Saey
The public's concerns over the Johnson & Johnson coronavirus vaccine are widespread, Post-ABC poll finds
By Scott Clement & Amy Goldstein
FDA ends Johnson & Johnson vaccine pause - POLITICO
By Sarah Owermohle, David Lim & Erin Banco
Emergent BioSolutions halts operations at its Baltimore plant, where J.&J. doses were ruined, at the F.D.A.'s request ...
By Sheryl Gay Stolberg
Johnson & Johnson Vaccine Will Be Available Again Soon
By Denise Grady, Julie Bosman & Noah Mercer Weiland